RT Book, Section
A1 Bax, Jeroen J.
A1 Marsan, Nina Ajmone
A1 Bijl, Pieter van der
A1 Treede, Hendrik
A1 DeBonis, Michele
A1 Prendergast, Bernard
A1 Iung, Bernard
A1 Delgado,  Victoria
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John S.
A2 Poppas, Athena
SR Print(0)
ID 1202445999
T1 Mitral Regurgitation
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1202445999
RD 2024/10/15
AB Content  UpdateMitraClip  Continues  to  Outperform  Medical  Therapy  Alone  at  5-years,  but  Event  Rates  Remain  HighThe  COAPT  trial  investigators  randomized  614  patients  with  heart  failure  with  left  ventricular  reduced  ejection  fraction  (20-50%)  on  maximally  tolerated  guideline-directed  medical  therapy  and  symptomatic  moderate-to-severe  or  severe  secondary  mitral  regurgitation  to  either  transcatheter  edge-to-edge  repair  (TEER)  with  the  MitraClip  (Abbott)  (n  =  302)  or  medical  therapy  alone  (n  =  312).  Read  More